Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Neurology|May 24, 2013
Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysisRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
The Journal of Pain|March 30, 2018
A Comparison of the Assay Sensitivity of Average and Worst Pain Intensity in Pharmacologic Trials: An ACTTION Systematic Review and Meta-AnalysisShannon M Smith, Mark P Jensen, Hua He, et al.
Journal of Pain Research|November 16, 2017
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health surveyMarco D DiBonaventura, Alesia Sadosky, Kristen Concialdi, et al.
Clinical Therapeutics|January 26, 2008
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studiesDaniel K Kajdasz, Smriti Iyengar, Durisala Desaiah, et al.
Journal of Clinical Epidemiology|November 25, 2015
Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic reviewJordan D Dworkin, Andrew McKeown, John T Farrar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomasSung-Suk Chae, Walid S Kamoun, Christian T Farrar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 7, 2013
Cerebral blood volume affects blood-brain barrier integrity in an acute transient stroke modelShuning Huang, Jeong Kon Kim, Dmitriy N Atochin, et al.
Current Medical Research and Opinion|December 17, 2020
Construct validity and reproducibility of the Prescription Opioid Misuse And Abuse Questionnaire (POMAQ)Karin S Coyne, Alexandra I Barsdorf, Brooke M Currie, et al.
Pain|June 19, 2026
Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trialsChristopher J Miller, Ian DeLorey, Warren B Bilker, et al.
Clinical Pharmacology and Therapeutics|January 9, 2023
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical TrialsLuana Colloca, Robert H Dworkin, John T Farrar, et al.
Pageof 29